Beam Therapeutics Inc 10-Q for FY2022 Q3
Beam Therapeutics Inc. (BEAM)
10-Q
2022-11-07
For: 2022-09-30
View Original
Added on
April 09, 2026
About this 10-Q
Beam Therapeutics Inc filed this 10-Q on November 7, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $15.8M
- up 1970.6% from $763K a year earlier
- Net loss
- $109.58M
- compared with a net loss of $28.12M a year earlier
- Diluted EPS
- -$1.56
- compared with -$0.42 a year earlier